CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-13 | ZENNER PATRICK J Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2023-11-13 | ZENNER PATRICK J Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | ZENNER PATRICK J Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | ZENNER PATRICK J Director | Returned to the company · Stock Option (Right to Buy) | −75,000 | $0.93 | $70K | 0 |
| 2023-11-13 | Sallin Aymeric Director | Returned to the company · Stock Option (Right to Buy) | −6,410 | 0 | ||
| 2023-11-13 | Sallin Aymeric Director | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2023-11-13 | Sallin Aymeric Director | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2023-11-13 | Sallin Aymeric Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2023-11-13 | Sallin Aymeric Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | Sallin Aymeric Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | Sallin Aymeric Director | Returned to the company · Stock Option (Right to Buy) | −75,000 | $0.93 | $70K | 0 |
| 2023-11-13 | Myers Scott Dunseth Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2023-11-13 | Myers Scott Dunseth Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2023-11-13 | Myers Scott Dunseth Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | Myers Scott Dunseth Director | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2023-11-13 | Myers Scott Dunseth Director | Returned to the company · Stock Option (Right to Buy) | −87,500 | $0.93 | $81K | 0 |
Page 16 of 16 · 316 trades